Supplementary Figures 1 - 2 from PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 1425K, Figure S1. (A) Human placenta stained with the rabbit monoclonal anti-PD-L1 (original lot concentration of 0.22 mg/ml) and showing membrane staining of syncytiotrophoblasts and, (B) the same case stained with the mouse monoclonal anti-PD-L1 (original lot concentration of 0.65 mg/ml). (C) Human tonsil stained with rabbit anti-PD-L1 antibody (original lot concentration of 1.55 mg/ml) and, (D) stained with the rabbit anti-PD-L1 antibody (original lot concentration of 0.22 mg/ml) and, (E) stained with the mouse anti-PD-L1 antibody (original lot concentration of 0.65 mg/ml). Figure S2. (A-C) Case of classical Hodgkin lymphoma stained with (A) the rabbit anti-PD-L1 antibody (original lot concentration of 1.55 mg/ml), (B) the rabbit anti-PD-L1 antibody (original lot concentration of 0.22 mg/ml, and (C) the mouse anti-PD-L1 antibody (original lot concentration of 0.65 mg/ml). (E-F) Case of EBV-negative PTLD stained with (D) the rabbit anti-PD-L1 antibody (original lot concentration of 1.55 mg/ml), (E) the rabbit anti-PD-L1 antibody (original lot concentration of 0.22 mg/ml, and (F) the mouse anti-PD-L1 antibody (original lot concentration of 0.65 mg/ml).
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361968206